MELSMON HUMAN PLACENTA 50*2ML JAPAN

MELSMON HUMAN PLACENTA 50*2ML JAPAN
MELSMON HUMAN PLACENTA 50*2ML JAPANMELSMON HUMAN PLACENTA 50*2ML JAPANMELSMON HUMAN PLACENTA 50*2ML JAPAN
รหัสสินค้า SKU-00651
หมวดหมู่ PLACENTA EXTRACTS FROM JAPAN
ราคาปกติ 16,000.00 บาท
ลดเหลือ 14,000.00 บาท
สถานะสินค้า พร้อมส่ง
ลงสินค้า 10 ต.ค. 2567
อัพเดทล่าสุด 4 มิ.ย. 2568
คงเหลือ ไม่จำกัด
จำนวน
ชิ้น
หยิบลงตะกร้า
บัตรประชาชน
บุ๊คแบ๊งค์
คุ้มครองโดย LnwPay
MELSMON HUMAN PLACENTA  Albumen Amino Acid Base Formula

This material is mainly composed of human placenta as the main component. The placenta used as a raw material has been tested for infectious diseases, various medical diagnoses, and high heat treatment for production, which is a safety measure to prevent infectious diseases. However, it is impossible to completely eliminate the risk of infection due to using human placenta as a raw material. Therefore, the need for medical treatment should be carefully diagnosed and used as little as necessary.



Compounds and characteristics

component
Tube type (2 ml)
Water-soluble extract of placenta 100 mg.
Additives
Tube (2 ml)
Benzyl alcohol 0.03mL
nature
Light yellow color
feature
Water soluble injection
pH
6.8-7.0
Osmotic pressure comparison
9~13 (to pure saline)

efficiency

Abnormal symptoms in menopausal women, abnormalities in lactation in mothers

How to use and dosage

1 time per day, 2 ml. every day or every other day, injected subcutaneously.

Precautions for use

1. Close control (use in the following patients requires close control)

Patients with allergies

2.Important precautions

"Explanation to Patients"
It must be explained to patients that in addition to the necessity for medical treatment, safety measures are taken to prevent the spread of infectious diseases in the production of this substance. However, using human placenta as an important raw material cannot completely eliminate the risk of infectious diseases.

(1) This substance is manufactured using human placenta in Japan with prior consent. The medical history, travel history, serological examination, etc. of all donors were checked for viral or bacterial infections, etc., and a nucleic acid amplification test (NAT) was performed. grnjv9i;0skg=nhv HBV-DNA, HCV-RNA, and HIV-1RNA were also performed.
However, there is still a possibility that viruses may be contaminated that cannot be detected by the NAT testing process.
This substance is manufactured using the hydrochloric acid hydrolysis process. During the manufacturing process, hydrochloric acid is heated to more than 101 ° C for more than 1 hour and sterilized with high-pressure steam at 121 ° C for 60 minutes to inactivate the virus. However, since human placenta is used as a raw material, the risk of infection cannot be completely eliminated. Therefore, its use should be closely monitored

(2). Currently, there are no reports of infection with mutated Creutzfeldt-Jakob disease (vCJD) caused by exposure to this drug, both domestically and internationally.
However, in theory, the risk of vCJD infection cannot be completely eliminated. When receiving the drug, patients must be given thorough information, and receiving the drug should be accompanied by a thorough diagnosis of the need for treatment.

Precautions when using

(1) Method of administration: This product is for subcutaneous injection only.
(2) Opening the tube: This product uses the "one-time easy tube cutting" method. After wiping the part to be opened with an alcohol swab, turn the opening symbol on the tube in the opposite direction to open it without using a file.

Side effects

Side effects

Of the 98 patients enrolled in the study, 19 (19.4%) experienced side effects, with the most important symptom being injection site redness and pain in 7 patients, accounting for 7.1% of all side effects reported in 36.8% of patients. This variation was considered clinically insignificant.

Major side effects

Because shock may occur, if any abnormal symptoms occur, stop giving the medication immediately and provide appropriate assistance.

Other side effects

If the following abnormalities occur, stop taking the medication immediately and provide support according to the symptoms.

Chills, palpitations, fever, rash, itching, etc. are abnormal hypersensitivity (less than 0.1-5%).
※If these abnormalities occur, stop taking the medication immediately.

Pain, swelling, and redness at the injection site (more than 5%)

CATEGORY

MF3 / MFIII จนมาถึง MF+ ยิ่งใหญ่จนเป็นตำนานเรื่องของเซลล์ [84]

MEMBER

STATISTIC

หน้าที่เข้าชม188,311 ครั้ง
ผู้ชมทั้งหมด116,007 ครั้ง
เปิดร้าน4 ส.ค. 2557
ร้านค้าอัพเดท31 ต.ค. 2568
พูดคุย-สอบถาม